NMPA Approval

Gliclazide Sustained-release Tablets

Approval Number

国药准字HJ20150283

Registration Date

March 20, 2024

Previous Approval Numbers

H20150283

Drug Information

Generic Name

格列齐特缓释片

Dosage Form

片剂

Strength

60mg

Drug Type

化学药品

Registration Date

March 20, 2024

Expiry Date

March 19, 2029

Company Address

50, rue Carnot, 92284 Suresnes Cedex

Company Address

905, route de Saran, 45520 Gidy

Empowering clinical research with data-driven insights and AI-powered tools.

格列齐特缓释片 - NMPA 批准文号 | MedPath